Definition Packaging Pharmacy 
FDA Law Blog: Biosimilars
SEPTEMBER 30, 2024
Another rejected proposal was a definition of “vaccine” (vaccines are exempt from Medicaid rebates), which would have limited this term to a product that is administered prophylactically – i.e., to prevent rather than treat a disease. that is not supported by the statute and applicable regulations.” 1396r-8(k)(3).
Agency IQ
AUGUST 4, 2023
a wholesaler or pharmacy) would be able to see a valid chain of custody for a product. In March, the agency finalized a long-awaited guidance document that provides specific definitions for key terms and concepts under the DSCSA – including the terms counterfeit, diverted, fraudulent transaction and unfit for distribution.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 17, 2020
These follow-on data provided the first definitive prospective evidence demonstrating anti-viral activity for a treatment regimen now available for COVID-19, and also further documented the ability of this treatment to decrease the need for further medical attention,” said George D. Have chronic kidney disease. Have diabetes.
Agency IQ
JUNE 16, 2023
Based on the results of its evaluation of nominated categories of drug products to date, as well as consultation with the Pharmacy Compounding Advisory Committee (PCAC), FDA is also proposing to include certain categories of drug products on these lists. The rule, will also, if finalized, address communication with State boards of pharmacy.
The Pharma Data
OCTOBER 28, 2020
Today’s data, involving an additional 524 patients from the ongoing Phase 2/3 trial, provides definitive final virology results and meets the clinical endpoint of reducing medical visits. TARRYTOWN, N.Y. , 28, 2020 /PRNewswire/ — . Regeneron has shared these results with the U.S.
The Pharma Data
JANUARY 12, 2021
Definition of High-Risk Patients. Monoclonal antibodies, such as casirivimab and imdevimab, may be associated with worse clinical outcomes when administered to hospitalized patients requiring high flow oxygen or mechanical ventilation with COVID-19. Have chronic kidney disease. Have diabetes.
The Pharma Data
NOVEMBER 20, 2020
Definition of High-Risk Patients. Monoclonal antibodies, such as casirivimab and imdevimab, may be associated with worse clinical outcomes when administered to hospitalized patients requiring high flow oxygen or mechanical ventilation with COVID-19. Have chronic kidney disease. Have diabetes. Are ?
Expert insights. Personalized for you.
57 
Let's personalize your content